Barclays
AVNS

Barclays’s Avanos Medical AVNS Stock Holding History

Barclays’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39,900
Closed -$2.28M – 7105
2018
Q2 		$2.28M Buy
+39,900
New +$2.11M ﹤0.01% 2456
2016
Q1 		– Sell
-72
Closed -$2K – 6131
2015
Q4 		$2K Sell
72
-60
-45% -$1.87K ﹤0.01% 5737
2015
Q3 		$4K Hold
132
– – ﹤0.01% 6102
2015
Q2 		$5K Sell
132
-108
-45% -$4.85K ﹤0.01% 6425
2015
Q1 		$12K Sell
240
-1,680
-88% -$77.8K ﹤0.01% 6104
2014
Q4 		$86K Buy
+1,920
New +$75.4K ﹤0.01% 5322

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Barclays's AVNS Position: Q2 2026 in Review

Barclays increased its Avanos Medical (AVNS) stake by 961% in Q2 2026, buying an estimated $3.1M and bringing the position to 146,207 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Barclays first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.7M in Q3 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Barclays held 146,207 shares of Avanos Medical worth $3.64M as of Q2 2026.
  • Barclays bought 132,421 Avanos Medical shares in Q2 2026, an estimated $3.1M.
  • Avanos Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2014 holding.
  • Barclays first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • Barclays's Avanos Medical position peaked at $5.7M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.